Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
The Hematologic Neoplasia Division is one of the largest divisions within the Department of Medical Oncology of the Dana-Farber Cancer Institute. The Division includes 49 faculty, 27 research scientists, and 87 research fellows as part of 22 independent investigator-led laboratory groups. The division occupies 36,000 square feet of wet lab space with $40 million dollars of external grant funding. In the Hematologic Neoplasia Division, physician-scientists and staff primarily study blood cancers including leukemia, lymphoma and myeloma and the immune responses required to eradicate blood cancers and other types of tumors. HN faculty are both physician-scientists and basic researchers and are members of the Department of Medicine at Harvard Medical School.
The Hematologic Neoplasia (HN) Department Administrator will work closely with the Division Chief, faculty and division/department administrative staff to manage the daily operations, financial matters, research grants and personnel issues of both faculty and staff. This position will work with the Division’s DGMS Managers to oversee all matters related to grants (pre and post award), as well as overall portfolio management from all sources of funding (federal, non-federal, gifts, and institutional). Portfolios include all external grant funding for 30 additional faculty members within the Disease Centers of Hematologic Malignancies. The HN Department Administrator will be responsible for $73 million in total current research funding from all sources. The successful candidate must share the faculty and staff’s passion for and commitment to cutting edge research that will benefit patients with blood cancers.
Overall Management and Operations
The Department Administrator should have the following qualifications and experience:
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.